Daily Insulin Dose and Cancer Risk Among Patients With Type 1 Diabetes

JAMA Oncol. 2022 Sep 1;8(9):1356-1358. doi: 10.1001/jamaoncol.2022.2960.

Abstract

This cohort study examines the incidence of cancer diagnosis and risk factors among patients on a daily regimen of insulin.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Diabetes Mellitus, Type 1* / chemically induced
  • Diabetes Mellitus, Type 1* / complications
  • Diabetes Mellitus, Type 1* / drug therapy
  • Drug Administration Schedule
  • Glycated Hemoglobin
  • Humans
  • Insulin / adverse effects
  • Neoplasms* / chemically induced
  • Neoplasms* / drug therapy
  • Neoplasms* / epidemiology

Substances

  • Glycated Hemoglobin A
  • Insulin